- Home
- SLS vs CFFI Comparison
SLS vs CFFI Comparison
Compare SLS & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLS | CFFI |
|---|---|---|
| Founded | 2012 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 218.0M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | SLS | CFFI |
|---|---|---|
| Price | $3.79 | $71.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 9.1M | 6.2K |
| Earning Date | 11-12-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.53% |
| EPS Growth | N/A | ★ 43.03 |
| EPS | N/A | ★ 8.09 |
| Revenue | N/A | ★ $125,432,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.97 |
| Revenue Growth | N/A | ★ 9.28 |
| 52 Week Low | $0.85 | $53.14 |
| 52 Week High | $3.99 | $89.90 |
Technical Indicators
Market Signals| Indicator | SLS | CFFI |
|---|---|---|
| Relative Strength Index (RSI) | 88.03 | 51.85 |
| Support Level | $2.60 | $67.83 |
| Resistance Level | $3.99 | $73.16 |
| Average True Range (ATR) | 0.32 | 2.26 |
| MACD | 0.15 | -0.43 |
| Stochastic Oscillator | 90.17 | 41.06 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.